Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Migraine Drug Recalled
11/05/2021
The FDA has issued a Class III recall for rizatriptan tablets.
The FDA has issued a Class III recall for rizatriptan tablets.
The FDA has issued a Class III...
11/05/2021
Pharmacy Learning Network

Advertisement

News
Muscle Relaxant Recalled
10/28/2021
A prescription injection used to relax muscles during surgery and medical procedures is being recalled.
A prescription injection used to relax muscles during surgery and medical procedures is being recalled.
A prescription injection used to...
10/28/2021
Pharmacy Learning Network
News
Depression Medication Recalled
10/28/2021
Lupin Pharmaceuticals Inc is recalling more than 1000 bottles of imipramine pamoate capsules following out-of-specification results from a dissolution test at the 9-month time point.
Lupin Pharmaceuticals Inc is recalling more than 1000 bottles of imipramine pamoate capsules following out-of-specification results from a dissolution test at the 9-month time point.
Lupin Pharmaceuticals Inc is...
10/28/2021
Pharmacy Learning Network
News
Heartburn Medication Recalled
10/28/2021
A Class II recall is active for an over-the-counter acid reducer.
A Class II recall is active for an over-the-counter acid reducer.
A Class II recall is active for...
10/28/2021
Pharmacy Learning Network

Advertisement

News
Pharmacist Involvement Helps Boost VTE Prophylaxis in Surgical Patients at High Risk
10/25/2021
According to research findings, a strategy characterized by active engagement of a multidisciplinary team at various stages of patient care significantly improved adherence to optimal perioperative venous thromboembolism prophylaxis in...
According to research findings, a strategy characterized by active engagement of a multidisciplinary team at various stages of patient care significantly improved adherence to optimal perioperative venous thromboembolism prophylaxis in...
According to research findings,...
10/25/2021
Pharmacy Learning Network
News
Two Firms Recall Hypokalemia Medications
10/22/2021
Potassium chloride products are being recalled by two firms, according to the recent FDA Enforcement Report.
Potassium chloride products are being recalled by two firms, according to the recent FDA Enforcement Report.
Potassium chloride products are...
10/22/2021
Pharmacy Learning Network
News
Class I Recall for Hypoglycemia Emergency Kits
10/22/2021
A Class I recall is in effect for a single lot of Eli Lilly & Company’s Glucagon Emergency Kit for Low Blood Sugar after a customer reported a vial containing glucagon in liquid rather than powder form.
A Class I recall is in effect for a single lot of Eli Lilly & Company’s Glucagon Emergency Kit for Low Blood Sugar after a customer reported a vial containing glucagon in liquid rather than powder form.
A Class I recall is in effect...
10/22/2021
Pharmacy Learning Network

Advertisement

News
Eye Solution Recalled
10/14/2021
Akorn Inc is recalling 10,210 bottles of betaxolol ophthalmic solution after 12-month stability testing identified microbial contamination.
Akorn Inc is recalling 10,210 bottles of betaxolol ophthalmic solution after 12-month stability testing identified microbial contamination.
Akorn Inc is recalling 10,210...
10/14/2021
Pharmacy Learning Network
News
Vertigo Drug Recalled
10/14/2021
The FDA is recalling a prescription medication used to treat vertigo associated with conditions affecting the vestibular system in adults.
The FDA is recalling a prescription medication used to treat vertigo associated with conditions affecting the vestibular system in adults.
The FDA is recalling a...
10/14/2021
Pharmacy Learning Network
News
Glycopeptide Antibacterial Treatment Under Class I Recall
10/14/2021
“Consumers, distributors, and retailers that are in possession of Firvanq from the affected lot should immediately stop using it and return it to the place of purchase,” Azurity Pharmaceuticals advised.
“Consumers, distributors, and retailers that are in possession of Firvanq from the affected lot should immediately stop using it and return it to the place of purchase,” Azurity Pharmaceuticals advised.
“Consumers, distributors, and...
10/14/2021
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use